RUHONG JIANG Sr.

Dr. Ruhong Jiang is the founder, chairman, president and chief executive officer of ASC Therapeutics Inc. (ASCTx). ASC Therapeutics is an independent biopharmaceutical company established as a spin-off from Applied StemCell, Inc. The company used more than 12 years of experience from Applied StemCell to build three technology platforms for the development of gene and cell therapies. These three platforms are for liver targeted gene therapy, gene editing technology and allogeneic cell therapy. The company has a team composed of dedicated scientists and industry veterans who firmly believe that gene and cell therapy is the future for the treatment of rare diseases.